Gabelli Funds’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$456K Sell
14,500
-20,000
-58% -$630K ﹤0.01% 1052
2025
Q4
$1.02M Hold
34,500
0.01% 905
2025
Q3
$871K Sell
34,500
-44,000
-56% -$1.07M 0.01% 942
2025
Q2
$1.88M Hold
78,500
0.01% 753
2025
Q1
$1.8M Buy
78,500
+2,000
+3% +$48.3K 0.01% 674
2024
Q4
$1.94M Buy
76,500
+12,000
+19% +$304K 0.01% 658
2024
Q3
$1.61M Buy
64,500
+9,500
+17% +$281K 0.01% 699
2024
Q2
$1.63M Buy
55,000
+5,000
+10% +$139K 0.01% 699
2024
Q1
$1.51M Buy
50,000
+15,000
+43% +$416K 0.01% 710
2023
Q4
$1M Sell
35,000
-26,000
-43% -$764K 0.01% 778
2023
Q3
$2.26M Sell
61,000
-500
-0.8% -$19.1K 0.02% 622
2023
Q2
$2.4M Buy
61,500
+2,300
+4% +$90.1K 0.02% 619
2023
Q1
$2.16M Sell
59,200
-1,600
-3% -$50.5K 0.02% 645
2022
Q4
$1.87M Buy
+60,800
New +$1.89M 0.01% 668

Other funds holding RTO

Gabelli Funds's RTO Position: Q1 2026 in Review

Gabelli Funds reduced its Rentokil (RTO) stake by 58% in Q1 2026, selling an estimated $630K and leaving 14,500 shares worth $456K. The position accounts for ﹤0.01% of the portfolio, ranked #1052.

Gabelli Funds first reported a position in RTO in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.4M in Q2 2023. 282 funds tracked by Wall St. Rank hold RTO as of Q1 2026.

  • Gabelli Funds held 14,500 shares of Rentokil worth $456K as of Q1 2026.
  • Gabelli Funds sold 20,000 Rentokil shares in Q1 2026, an estimated $630K.
  • Rentokil made up ﹤0.01% of Gabelli Funds's portfolio in Q1 2026, its #1052 holding.
  • Gabelli Funds first reported a position in Rentokil in Q4 2022 and has held it in 14 quarters since.
  • Gabelli Funds's Rentokil position peaked at $2.4M in Q2 2023.
  • 282 funds tracked by Wall St. Rank held Rentokil as of Q1 2026.

Based on Gabelli Funds's 13F filing for Q1 2026, filed 14 May 2026.